Merck
MRK
#50
Rank
C$415.90 B
Marketcap
C$168.39
Share price
0.44%
Change (1 day)
56.61%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): C$4.87

According to Merck's latest financial reports the company's current EPS (TTM) is C$4.96. In 2025 the company made an earnings per share (EPS) of C$10.16 an increase over its 2024 EPS that were of C$9.42.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$4.87-52.03%
2025C$10.167.81%
2024C$9.424308.46%
2023C$0.21-97.32%
2022C$7.9910.92%
2021C$7.2084.68%
2020C$3.90-27.2%
2019C$5.3663.44%
2018C$3.28151.11%
2017C$1.31-54.58%
2016C$2.8730.21%
2015C$2.21-61.99%
2014C$5.80180.51%
2013C$2.07-31.82%
2012C$3.036.62%
2011C$2.85

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.18 145.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$9.79 97.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.83-63.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$5.03 1.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$39.35 693.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$20.19 307.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$3.57-28.05%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$4.96 0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$5.42 9.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$1.91-61.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel